Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
A requirement to secure Azithromycin and Dexamethasone products for trials for Covid 19 - urgent delivery required for available stocks
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Aspen Pharma Ireland Ltd | FC035080 | ~£305,794 estimated from lot values | - |
| Hameln Pharmaceuticals Ltd | 01034697 | ~£305,794 estimated from lot values | - |
| Milpharm Ltd | 03354124 | ~£305,794 estimated from lot values | - |
| Rosemont Pharmaceuticals | 00924648 | ~£305,794 estimated from lot values | - |
| Teva UK Ltd | 00302461 | ~£305,794 estimated from lot values | - |
Government spending data: These suppliers have received £91,781,146 in 1,895 payments (over £25k) from Department of Health and Social Care, NHS England, Guy's and St Thomas' NHS FT, Maidstone and Tunbridge Wells NHS Trust, BEIS (2010-04-15 to 2026-03-12).